Rapid detection of extended-spectrum β-lactamase-producing Gram-negative bacilli in blood cultures

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 3, 2007, Pages 652-654

  Jain, Sarjana ^a   Andrews, Jenny ^a   Fraise, Adam ^a   Brenwald, Nigel ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

Bacteraemia; Chromogenic cephalosporin; HMRZ 86

Indexed keywords

CEFPODOXIME; CEPHALOSPORIN; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; HMRZ 86; UNCLASSIFIED DRUG;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; BLOOD CULTURE; CITROBACTER; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; CULTURE MEDIUM; FALSE POSITIVE RESULT; GRAM NEGATIVE BACTERIUM; HYDROLYSIS; KLEBSIELLA; NONHUMAN; PROTEUS MIRABILIS; SALMONELLA; SERRATIA MARCESCENS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BLOOD; CEPHALOSPORINS; CLAVULANIC ACID; COLOR; CULTURE MEDIA; ENZYME INHIBITORS; FALSE POSITIVE REACTIONS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; HYDROLYSIS;

EID: 34548133666     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm256     Document Type: Article

References (7)

1. Kim YK, Pal H, Lee HJ et al. Bloodstream infections by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: Epidemiology and clinical outcome. Antimicrob Agents Chemother 2002; 46: 1481-91.
2. Endimiani A, Luzzaro F, Brigante G et al. Proteus mirabilis bloodstream infection: Risk factors and treatment outcome related to the expression of extended-spectrum β-lactamases. Antimicrob Agents Chemother 2005; 49: 2598-605.
3. Anderson DJ, Engemann JJ, Harrell LJ et al. Predictors of mortality in patients with bloodstream infections due to ceftazidime-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother 2006; 50: 1715-20.
4. Rodriguez-Bano J, Navarro MD, Romero L et al. Bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli in the CTX-M era: A new clinical challenge. Clin Infect Dis 2006; 43 1407-14.
5. Hanaki H, Kubo R, Nakano T et al. Characterization of HMRZ-86: A novel chromogenic cephalosporin for the detection of extended-spectrum β-lactamases. J Antimicrob Chemother 2004; 53: 888-9.
6. Colodner R, Reznik B, Gal V et al. Evaluation of a novel kit for the rapid detection of extended-spectrum β-lactamases. Eur J Clin Microbiol Infect Dis 2006; 25: 49-51.
7. Livermore DM, Brown DFJ. Detection of β-lactamase-mediated resistance. J Antimicrob Chemother 2001; 48 Suppl S1: 59-64.